DKA - Nursing Case Study

Pathophysiology

• Primary mechanism: In diabetic ketoacidosis (DKA), insulin deficiency leads to increased lipolysis, causing excess free fatty acids to be converted into ketone bodies by the liver, resulting in metabolic acidosis.

• Secondary mechanism: The absence of insulin also leads to unrestrained gluconeogenesis and glycogenolysis, causing severe hyperglycemia. This hyperglycemia induces osmotic diuresis, leading to dehydration and electrolyte imbalances.

• Key complication: The combination of acidosis, dehydration, and electrolyte disturbances, particularly hypokalemia, can lead to critical complications such as cardiac arrhythmias and impaired organ perfusion.

Patient Profile

Demographics:

45-year-old female, high school teacher

History:

• Key past medical history: Type 1 Diabetes Mellitus diagnosed 20 years ago, hypertension

• Current medications: Insulin glargine, lisinopril, metformin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Abdominal pain and nausea

• Key symptoms: Polyuria, polydipsia, fatigue, confusion

• Vital signs: Temperature 100.4°F, heart rate 112 bpm, respiratory rate 26 breaths per minute, blood pressure 92/60 mmHg, blood glucose 420 mg/dL

Section 1

As the clinical team initiates treatment for this 45-year-old female experiencing diabetic ketoacidosis (DKA), initial assessment findings reveal several critical issues requiring prompt attention. Upon conducting a thorough physical examination, the patient exhibits Kussmaul respirations, a compensatory mechanism to counteract the metabolic acidosis. Her skin is noted to be dry and tenting, indicating significant dehydration. Furthermore, a basic metabolic panel is ordered, revealing a serum potassium level of 3.0 mEq/L, confirming hypokalemia, a common and dangerous complication of DKA. This electrolyte imbalance poses an immediate risk for cardiac arrhythmias and requires careful monitoring and management.

In response to these findings, the medical team initiates aggressive fluid resuscitation with isotonic saline to address her dehydration and improve perfusion. Simultaneously, an insulin infusion is started to reduce her blood glucose levels and suppress ketone production. Given her hypokalemia, potassium replacement therapy is cautiously administered, closely monitoring her cardiac rhythm and serum potassium levels to prevent rebound hyperkalemia as insulin drives potassium back into the cells.

Despite these interventions, the complexity of DKA presents further challenges. Within a few hours, the patient begins to show signs of altered mental status, with increasing confusion and disorientation. Repeat laboratory tests reveal a worsening anion gap metabolic acidosis, with an arterial blood gas showing a pH of 7.22 and bicarbonate level of 10 mEq/L. The persistent acidosis suggests that despite initial treatment, the underlying metabolic derangements are not yet fully corrected, prompting the team to reassess the treatment strategy. This necessitates a careful evaluation of ongoing fluid and electrolyte replacement, insulin therapy, and the potential need for additional supportive measures to stabilize her condition and prevent further deterioration.

Section 2

As the clinical team continues to manage the patient's condition, they encounter new diagnostic results that provide further insight into her deteriorating status. A repeat arterial blood gas reveals a pH of 7.15, indicating a worsening acidemia. The serum potassium level has increased to 3.5 mEq/L following cautious potassium replacement, but remains on the lower side of normal. Concurrently, an elevated serum lactate level of 4.5 mmol/L is identified, suggesting the development of lactic acidosis, possibly due to tissue hypoperfusion and ongoing metabolic stress. Additionally, a chest X-ray ordered to evaluate potential sources of infection or other complications shows mild pulmonary congestion, raising concerns about the patient's fluid balance and possible fluid overload.

In response to these findings, the medical team intensifies their efforts to correct the underlying metabolic disturbances. They adjust the rate of insulin infusion to more effectively lower blood glucose and ketone levels, while carefully balancing fluid administration to prevent exacerbating pulmonary congestion. The team also considers the possibility of an underlying infection or other precipitating factors for her DKA, prompting the initiation of broad-spectrum antibiotics after obtaining blood cultures. Close monitoring of her cardiac rhythm continues due to the risk of arrhythmias from the fluctuating potassium levels.

As the team works to stabilize the patient, they recognize the need for multidisciplinary collaboration. A consultation with a nephrologist is requested to evaluate her renal function and guide further management of her electrolyte imbalances. The team also engages with a critical care specialist to assess her respiratory status and determine if additional respiratory support is warranted, given her altered mental status and the potential for respiratory compromise. Through these coordinated efforts, the team aims to address the multifaceted challenges of this complex DKA case and prevent further complications.

Section 3

As the team continues to monitor the patient, new diagnostic results reveal a slight improvement in her blood glucose levels, now at 280 mg/dL, down from an initial 480 mg/dL. However, despite the adjustment in insulin therapy, the ketone levels remain elevated, indicating ongoing ketogenesis. The arterial blood gas analysis shows a persistent metabolic acidosis with a pH of 7.20, HCO3- of 10 mEq/L, and PaCO2 of 25 mmHg, suggesting partial respiratory compensation but an inadequate correction of the acid-base imbalance. Furthermore, the repeat serum lactate level has slightly increased to 5.0 mmol/L, exacerbating concerns about potential tissue hypoperfusion or sepsis.

The patient's vital signs also reflect a concerning trend. She is tachycardic with a heart rate of 115 bpm, blood pressure has dropped slightly to 88/54 mmHg, and her respiratory rate has increased to 28 breaths per minute, suggesting compensatory mechanisms are being overwhelmed. Her oxygen saturation remains stable at 95% on 2L of oxygen via nasal cannula, but her altered mental status persists, with increased confusion and lethargy. These findings prompt the team to consider the possibility of septic shock as a complicating factor in her DKA, necessitating an urgent reassessment of her hemodynamic status and fluid management strategy.

In response to these developments, the medical team decides to intensify their interventions. They initiate a norepinephrine infusion to support her blood pressure and improve tissue perfusion. Simultaneously, they reassess her fluid status with the help of a nephrologist to ensure adequate hydration without worsening pulmonary congestion. The possibility of infection is further explored with additional cultures and imaging as needed. The critical care specialist evaluates her respiratory function, considering the potential need for non-invasive ventilation to prevent respiratory fatigue. Through these targeted actions, the team aims to stabilize the patient's condition, correct the underlying metabolic derangements, and address any emerging complications, setting the stage for the next steps in her critical care journey.

Section 4

Response to Interventions

As the medical team implements the intensified interventions, the patient's clinical status begins to show subtle signs of improvement. The norepinephrine infusion effectively raises her blood pressure, which stabilizes at 96/60 mmHg, while her heart rate decreases slightly to 105 bpm, indicating a positive response to the vasopressor support. The nephrologist's assessment leads to a tailored fluid management plan, balancing isotonic fluids to maintain intravascular volume without exacerbating any potential fluid overload. This strategic adjustment helps improve her perfusion status, as reflected by a gradual reduction in her serum lactate levels, now at 4.2 mmol/L.

Despite these positive trends, the patient's metabolic acidosis remains a critical concern. Her arterial blood gas analysis shows a slight improvement, with a pH of 7.24 and HCO3- of 12 mEq/L, yet the acid-base imbalance persists. The critical care specialist closely monitors her respiratory function, and while her respiratory rate remains elevated at 26 breaths per minute, she demonstrates no signs of respiratory fatigue. Consequently, the decision is made to continue monitoring her respiratory status without escalating to non-invasive ventilation at this stage.

In the context of potential sepsis, empirical broad-spectrum antibiotics are initiated, pending the results of additional cultures. The team remains vigilant for any signs of infection, with close monitoring of her white blood cell count, which currently stands at 15,000/mm^3, and further imaging studies planned to identify any occult sources. Through these interventions, the team aims to support the patient's hemodynamic stability and address the multifaceted challenges presented by her condition, paving the way for ongoing assessment and adjustment of her treatment plan.

Section 5

As the patient continues under close observation, a change in her status becomes evident. Her blood glucose levels, initially presenting at a critically high 580 mg/dL upon admission, have decreased to 280 mg/dL with the administration of intravenous insulin. However, the nursing staff notes an unexpected complication: the patient begins to exhibit signs of hypokalemia. Her latest lab values reveal a potassium level of 3.0 mEq/L, prompting immediate concern for potential cardiac instability. The critical care team quickly initiates potassium replacement therapy, carefully balancing it with ongoing insulin administration to prevent further shifts in her electrolyte balance.

In conjunction with these developments, the patient starts to show signs of altered mental status. She appears increasingly lethargic, with a Glasgow Coma Scale score declining from 14 to 12, which raises a red flag for the team. This change necessitates a thorough re-evaluation of her overall condition. The team considers the possibility of cerebral edema or worsening metabolic derangement, particularly given her persistent acidosis. A stat head CT is ordered to rule out any acute intracranial events, while repeat arterial blood gases are requested to assess any further deterioration in her acid-base status.

The evolving situation requires the healthcare team to employ critical reasoning to integrate these new findings into the ongoing management plan. The balance between correcting metabolic derangements and preventing treatment-related complications becomes increasingly delicate. The team must remain vigilant, anticipating potential pitfalls while adjusting the therapeutic approach to navigate this complex clinical picture effectively. These developments drive the need for continuous monitoring and timely interventions, setting the stage for the next steps in her care journey.